Add to ORKGAim: To establish if GP-led integrated melanoma follow-up is feasible, and comparable to hospital-based follow-up, in terms of patient satisfaction, guideline adherence, quality of life and cost. Methods: Intervention design: GP-led integrated melanoma follow-up was designed and tested according to the MRC framework for the design and evaluation of complex healthcare interventions. Exploratory randomised trial: An exploratory randomised trial involving 35 practices and 142 patients was conducted to determine whether patients were more satisfied with the GP-led follow-up than hospital-based follow-up. The study also explored guideline adherence; health-related quality of life; and costs. Parallel qualitative interviews: Semi-structured inter...
Objectives and Design: The MELFO (MELanoma FOllow-up) study is an international phase III randomized...
Abstract Background Melanoma incidence has quadrupled since 1970 and melanoma is now the second most...
BACKGROUND: Most subsequent new primary or recurrent melanomas might be self-detected if patients ar...
BACKGROUND: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Background: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Investigating patients’ reports on the quality and consistency of melanoma follow-up care in Austral...
Introduction: Follow-up guidelines for melanoma greatly differ in the methods of screening for recur...
Background: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...
BACKGROUND: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...
Background Clinical practice guidelines should aim to assist clinicians in making evidence-based cho...
Investigating patients’ reports on the quality and consistency of melanoma follow-up care in Austral...
Background: A history of cutaneous malignancies puts patients at an increased risk of developing add...
Guidelines for evidence-based follow-up in melanoma patients are not available. This study examined ...
INTRODUCTION: Melanoma is the fifth most common cancer in the UK. Incidence rates have quadrupled ov...
Purpose: To develop more evidence-based guidelines for the frequency of patient follow-up after trea...
Objectives and Design: The MELFO (MELanoma FOllow-up) study is an international phase III randomized...
Abstract Background Melanoma incidence has quadrupled since 1970 and melanoma is now the second most...
BACKGROUND: Most subsequent new primary or recurrent melanomas might be self-detected if patients ar...
BACKGROUND: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Background: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Investigating patients’ reports on the quality and consistency of melanoma follow-up care in Austral...
Introduction: Follow-up guidelines for melanoma greatly differ in the methods of screening for recur...
Background: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...
BACKGROUND: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...
Background Clinical practice guidelines should aim to assist clinicians in making evidence-based cho...
Investigating patients’ reports on the quality and consistency of melanoma follow-up care in Austral...
Background: A history of cutaneous malignancies puts patients at an increased risk of developing add...
Guidelines for evidence-based follow-up in melanoma patients are not available. This study examined ...
INTRODUCTION: Melanoma is the fifth most common cancer in the UK. Incidence rates have quadrupled ov...
Purpose: To develop more evidence-based guidelines for the frequency of patient follow-up after trea...
Objectives and Design: The MELFO (MELanoma FOllow-up) study is an international phase III randomized...
Abstract Background Melanoma incidence has quadrupled since 1970 and melanoma is now the second most...
BACKGROUND: Most subsequent new primary or recurrent melanomas might be self-detected if patients ar...